Phenomenal thesis defense by #DrSeunghunHan presenting his research efforts on rare germline variants in cancer, with a focus on #RCC
Work done under the outstanding mentorship of the one and only @VanAllenLab@DanaFarber@harvardmed
Extremely excited and over the moon to have matched @BIDMC_IM@harvardmed !!!
This would not have been possible without the incredible support of my exceptional mentors @DrChoueiri@VanAllenLab@BraunMDPhD
Missing my parents.
Excited to share a fun weekend collaboration w/ @djin31 in celebration of #WomensDay! We used #ChatGPT and #DALLE2 to generate a children's storybook featuring female protagonists while celebrating the spirit of curiosity.
https://t.co/fJbo2FuWDL
Excited to see our work published. This initiative gave us the ability to diversify the cohort for rare cancers and to drive treatments for some patients. I would like to thank @DSolit@VanAllenLab@BarbaraSolit@sabrinaycamp Tina Alano and all my co-authors for your support.
Was a pleasure contributing to this study that partnered with patients w/ select rare cancers to facilitate free(!) tumor genomic profiling in an effort to better characterize these tumors and guide treatment
Congrats to @SeyramNaa and the Make-an-IMPACT team for the recent paper in @CCR_AACR "Overcoming barriers to tumor genomic profiling through direct-to-patient outreach." Here, we partnered with patient advocates to offer MSK-IMPACT testing to patients with select rare cancers.
Big congrats to @SeyramNaa@DSolit@BarbaraSolit@sabrinaycamp et al on this study - a joy to work with you all on this, and a brilliant program for patient-partnered cancer research, especially rare cancers!
We asked what would happen if we flipped a research paradigm and partnered with prostate cancer patients to bring genomics research to them
At their doorsteps
Wherever they live...
@jettcrowdis@DanaFarber@broadinstitute@EmCollective@CellGenomics [1/n] https://t.co/WROlYNfXzP
The MPCproject is a first-of-its-kind data-gathering initiative dedicated to better understand the genetics and biology of Metastatic Prostate Cancer. In @CellGenomics, researchers have reported the results of the first 4 years of the project. Read more: https://t.co/5ClhxeauXL
Great work by Seyram Doe-Tetteh, Sabrina Camp and the entire Make-an-IMPACT team for their work reducing barriers to NGS for rare cancer patients. @MSKCancerCenter@DanaFarber Thanks for all you do for our patients.
Our latest - introducing the Molecular Oncology Almanac (MOAlmanac): paired clinical interpretation algorithm + knowledge base for precision cancer medicine @moalmanac
Congrats @brendan_reardon et al! @DanaFarber@broadinstitute https://t.co/86JdStRgEi @NatureCancer [1/12]
For #ProstateCancerAwarenessMonth, an update on the Metastatic Prostate Cancer Project @PrCaProject & bringing patient-driven cancer research to everyone's doorsteps @broadinstitute@DanaFarber @count_me_in @SU2C et al. - please share! https://t.co/hRrch4ZVHr [1/9]
Online today in @ScienceMagazine! We observe a similar distribution of de novo mutations in children of Chernobyl cleanup workers and evacuees as seen in the general population, suggesting a lack of transgenerational effect.
@MeredithYeager @NCIChanock
https://t.co/htCys0rHf3